 | • レポートコード：GIR-22F19315 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Fc Fusion Protein for Autoimmune Disease Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の自己免疫疾患用Fc融合タンパク質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 自己免疫疾患用Fc融合タンパク質市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・オレンシア、エンブレル アプリケーション別セグメントは次のように区分されます。 ・関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他 世界の自己免疫疾患用Fc融合タンパク質市場の主要な市場プレーヤーは以下のとおりです。 ・Bristol-Myers Squibb、Amgen、Pfizer、3SBIO、Celgen Biopharma 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、自己免疫疾患用Fc融合タンパク質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な自己免疫疾患用Fc融合タンパク質メーカーの企業概要、2019年～2022年までの自己免疫疾患用Fc融合タンパク質の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な自己免疫疾患用Fc融合タンパク質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別自己免疫疾患用Fc融合タンパク質の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの自己免疫疾患用Fc融合タンパク質のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での自己免疫疾患用Fc融合タンパク質市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および自己免疫疾患用Fc融合タンパク質の産業チェーンを掲載しています。 ・第13、14、15章では、自己免疫疾患用Fc融合タンパク質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 自己免疫疾患用Fc融合タンパク質の概要 - タイプ別分析（2017年vs2021年vs2028年）：オレンシア、エンブレル - アプリケーション別分析（2017年vs2021年vs2028年）：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他 - 世界の自己免疫疾患用Fc融合タンパク質市場規模・予測 - 世界の自己免疫疾患用Fc融合タンパク質生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bristol-Myers Squibb、Amgen、Pfizer、3SBIO、Celgen Biopharma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：オレンシア、エンブレル ・アプリケーション別分析2017年-2028年：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他 ・自己免疫疾患用Fc融合タンパク質の北米市場分析 - 自己免疫疾患用Fc融合タンパク質の北米市場：タイプ別市場規模2017年-2028年 - 自己免疫疾患用Fc融合タンパク質の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・自己免疫疾患用Fc融合タンパク質のヨーロッパ市場分析 - ：自己免疫疾患用Fc融合タンパク質のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：自己免疫疾患用Fc融合タンパク質のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・自己免疫疾患用Fc融合タンパク質のアジア太平洋市場分析 - 自己免疫疾患用Fc融合タンパク質のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 自己免疫疾患用Fc融合タンパク質のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・自己免疫疾患用Fc融合タンパク質の南米市場分析 - 自己免疫疾患用Fc融合タンパク質の南米市場：タイプ別市場規模2017年-2028年 - 自己免疫疾患用Fc融合タンパク質の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・自己免疫疾患用Fc融合タンパク質の中東・アフリカ市場分析 - 自己免疫疾患用Fc融合タンパク質の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 自己免疫疾患用Fc融合タンパク質の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fc Fusion Protein for Autoimmune Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fc Fusion Protein for Autoimmune Disease market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Rheumatoid Arthritis accounting for % of the Fc Fusion Protein for Autoimmune Disease global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Orencia segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fc Fusion Protein for Autoimmune Disease include Bristol-Myers Squibb, Amgen, Pfizer, 3SBIO, and Celgen Biopharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fc Fusion Protein for Autoimmune Disease market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Orencia
Enbrel
Market segment by Application can be divided into
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
The key market players for global Fc Fusion Protein for Autoimmune Disease market are listed below:
Bristol-Myers Squibb
Amgen
Pfizer
3SBIO
Celgen Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fc Fusion Protein for Autoimmune Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fc Fusion Protein for Autoimmune Disease, with price, sales, revenue and global market share of Fc Fusion Protein for Autoimmune Disease from 2019 to 2022.
Chapter 3, the Fc Fusion Protein for Autoimmune Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fc Fusion Protein for Autoimmune Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fc Fusion Protein for Autoimmune Disease market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fc Fusion Protein for Autoimmune Disease.
Chapter 13, 14, and 15, to describe Fc Fusion Protein for Autoimmune Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Fc Fusion Protein for Autoimmune Disease Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fc Fusion Protein for Autoimmune Disease Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Orencia
1.2.3 Enbrel
1.3 Market Analysis by Application
1.3.1 Overview: Global Fc Fusion Protein for Autoimmune Disease Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Juvenile Idiopathic Arthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Other
1.4 Global Fc Fusion Protein for Autoimmune Disease Market Size & Forecast
1.4.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume (2017-2028)
1.4.3 Global Fc Fusion Protein for Autoimmune Disease Price (2017-2028)
1.5 Global Fc Fusion Protein for Autoimmune Disease Production Capacity Analysis
1.5.1 Global Fc Fusion Protein for Autoimmune Disease Total Production Capacity (2017-2028)
1.5.2 Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fc Fusion Protein for Autoimmune Disease Market Drivers
1.6.2 Fc Fusion Protein for Autoimmune Disease Market Restraints
1.6.3 Fc Fusion Protein for Autoimmune Disease Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product and Services
2.1.4 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Fc Fusion Protein for Autoimmune Disease Product and Services
2.2.4 Amgen Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Fc Fusion Protein for Autoimmune Disease Product and Services
2.3.4 Pfizer Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 3SBIO
2.4.1 3SBIO Details
2.4.2 3SBIO Major Business
2.4.3 3SBIO Fc Fusion Protein for Autoimmune Disease Product and Services
2.4.4 3SBIO Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Celgen Biopharma
2.5.1 Celgen Biopharma Details
2.5.2 Celgen Biopharma Major Business
2.5.3 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product and Services
2.5.4 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fc Fusion Protein for Autoimmune Disease Breakdown Data by Manufacturer
3.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fc Fusion Protein for Autoimmune Disease
3.4 Market Concentration Rate
3.4.1 Top 3 Fc Fusion Protein for Autoimmune Disease Manufacturer Market Share in 2021
3.4.2 Top 6 Fc Fusion Protein for Autoimmune Disease Manufacturer Market Share in 2021
3.5 Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fc Fusion Protein for Autoimmune Disease Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fc Fusion Protein for Autoimmune Disease Market Size by Region
4.1.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Region (2017-2028)
4.1.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2028)
4.2 North America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.3 Europe Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.4 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.5 South America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.6 Middle East and Africa Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Type (2017-2028)
5.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Type (2017-2028)
5.3 Global Fc Fusion Protein for Autoimmune Disease Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Application (2017-2028)
6.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Application (2017-2028)
6.3 Global Fc Fusion Protein for Autoimmune Disease Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
7.2 North America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
7.3 North America Fc Fusion Protein for Autoimmune Disease Market Size by Country
7.3.1 North America Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
7.3.2 North America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
8.2 Europe Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
8.3 Europe Fc Fusion Protein for Autoimmune Disease Market Size by Country
8.3.1 Europe Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
8.3.2 Europe Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
9.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
9.3 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Size by Region
9.3.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
10.2 South America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
10.3 South America Fc Fusion Protein for Autoimmune Disease Market Size by Country
10.3.1 South America Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
10.3.2 South America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
11.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
11.3 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Size by Country
11.3.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fc Fusion Protein for Autoimmune Disease and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fc Fusion Protein for Autoimmune Disease
12.3 Fc Fusion Protein for Autoimmune Disease Production Process
12.4 Fc Fusion Protein for Autoimmune Disease Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fc Fusion Protein for Autoimmune Disease Typical Distributors
13.3 Fc Fusion Protein for Autoimmune Disease Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer